Clinical Trial Update: Nasacort AQ Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Children With Allergic Rhinitis [Phase 4]

View source ↗

Summary

Phase 4 study of Nasacort AQ (triamcinolone acetonide nasal spray) in children with allergic rhinitis evaluated HPA axis effects; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Nasacort AQ (triamcinolone acetonide)

Snippet

Sponsor: Sanofi | Conditions: Rhinitis, Allergic, Perennial and/or Seasonal | Phase 4 | Status: COMPLETED | Results posted: 2011-10-28